Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

[1]  S. Hilsenbeck,et al.  Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells , 2010, Breast Cancer Research and Treatment.

[2]  H. Park,et al.  Expression of androgen receptors in primary breast cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Rohit Bhargava,et al.  Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation , 2010, Modern Pathology.

[4]  Joon Jeong,et al.  The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast Cancer. , 2009, Japanese journal of clinical oncology.

[5]  A. Ashworth,et al.  Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray‐based CGH analysis , 2009, The Journal of pathology.

[6]  Li Jia,et al.  Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. , 2009, Cancer research.

[7]  R. Gelber,et al.  Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  Charles M. Perou,et al.  Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.

[9]  W. Gerald,et al.  Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer , 2009, Clinical Cancer Research.

[10]  Katsunobu Sakurai,et al.  Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers , 2008, International Journal of Clinical Oncology.

[11]  K. Knudsen,et al.  Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult. , 2006, Cancer research.

[12]  A. Sapino,et al.  Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure , 2006, Virchows Archiv.

[13]  W. Sauerbrei,et al.  REporting recommendations for tumor MARKer prognostic studies (REMARK) , 2006, Breast Cancer Research and Treatment.

[14]  K. Wernecke,et al.  Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer , 2006, Virchows Archiv.

[15]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.

[16]  H. Denk,et al.  Androgen receptors frequently are expressed in breast carcinomas , 2003, Cancer.

[17]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Papotti,et al.  Expression of Apocrine Differentiation Markers in Neuroendocrine Breast Carcinomas of Aged Women , 2001, Modern Pathology.

[20]  Alexander Marks,et al.  Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers , 2001, Breast Cancer Research and Treatment.

[21]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[22]  T. H. van der Kwast,et al.  The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters. , 1996, European journal of cancer.

[23]  R. Bryan,et al.  Androgen receptors in breast cancer , 1984, Cancer.

[24]  S. Leung,et al.  Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients , 2009, Breast Cancer Research and Treatment.

[25]  A. Agrawal,et al.  Androgen receptors as a prognostic and predictive factor in breast cancer. , 2008, Folia histochemica et cytobiologica.

[26]  Ian O Ellis,et al.  Prognostic markers in triple‐negative breast cancer , 2007, Cancer.

[27]  Z. Gatalica,et al.  Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. , 1997, Pathology, research and practice.